Skip Nav

HIV/AIDS News

Text Size

HIV/AIDS News Search Results

123 news items were found about Resistance.

From:

To:

FDA Approves New Combination Pill for HIV Treatment for Some Individuals

Date: August 27, 2012
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/1275/fda-approves-new-combination-pill-for-hiv-treatment-for-some-individuals/

NIH Scientists to Test Maraviroc-Based Drug Regimens for HIV Prevention

Date: July 18, 2012
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/1257/nih-scientists-to-test-maraviroc-based-drug-regimens-for-hiv-prevention/

FDA Approves First Drug (Truvada) for Reducing the Risk of HIV Infection

Date: July 16, 2012
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/1254/fda-approves-first-drug-(truvada)-for-reducing-the-risk-of-hiv-infection/

HIV Superinfection in Uganda May Be More Common than Previously Thought

Date: June 7, 2012
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/1245/hiv-superinfection-in-uganda-may-be-more-common-than-previously-thought/

Approval of Complera: emtricitabine/rilpivirine/tenofovir DF fixed dose combination - August 10, 2011

Date: August 10, 2011
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/909/approval-of-complera-emtricitabine-rilpivirine-tenofovir-df-fixed-dose-combination---august-10-2011/

Statement of Anthony S. Fauci, M.D., and Jack Whitescarver, Ph.D., National Institutes of Health, on the 30th Anniversary of the First Reported Cases of AIDS - June 2, 2011

Date: June 2, 2011
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/905/statement-of-anthony-s-fauci-md-and-jack-whitescarver-phd- national-institutes-of-health-on-the-30th-anniversary-of-the-first-reported-cases-of-aids---june-2-2011/

Approval of Edurant (rilpivirine), a new NNRTI, for the Treatment of HIV in Treatment Naive Patients - May 20, 2011

Date: May 20, 2011
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/902/approval-of-edurant-(rilpivirine)-a-new-nnrti-for-the-treatment-of-hiv-in-treatment-naive-patients---may-20-2011/

NIH Study Examines Best Time for Healthy HIV-infected People to Begin Antiretrovirals - March 7, 2011

Date: March 7, 2011
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/896/nih-study-examines-best-time-for-healthy-hiv-infected-people-to-begin-antiretrovirals---march-7-2011/

NIH Studies Influence Revision of WHO Guidelines for Treating HIV-Infected Women and Infants - October 13, 2010

Date: October 13, 2010
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/886/nih-studies-influence-revision-of-who-guidelines-for-treating-hiv-infected-women-and-infants---october-13-2010/

New Kaletra (lopinavir/ritonavir) Tablets and Oral Solution once daily dosing regimen in certain adult patients

Date: April 28, 2010
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/864/new-kaletra-(lopinavir-ritonavir)-tablets-and-oral-solution-once-daily-dosing-regimen-in-certain-adult-patients/

Atripla label update reflects new efficacy, safety and resistance data in treatment experienced patients - January 7, 2010

Date: January 8, 2010
http://www.fda.gov/ForConsumers/ByAudience/ForPatientAdvocates/HIVandAIDSActivities/ucm196950.htm

Statement from the National Institutes of Health on World AIDS Day 2009

Date: December 1, 2009
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/850/statement-from-the-national-institutes-of-health-on-world-aids-day-2009/

Updated Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents available

Date: December 1, 2009
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/849/updated-guidelines-for-the-use-of-antiretroviral-agents-in-hiv-1-infected-adults-and-adolescents-available/

Clinical Trial of Antiretroviral-based HIV Prevention Strategies for Women Now Under Way

Date: September 16, 2009
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/839/clinical-trial-of-antiretroviral-based---hiv-prevention-strategies-for-women-now-under-way/

NIAID Leaders Outline Research Agenda for Universal, Voluntary HIV Testing and Treatment

Date: June 9, 2009
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/835/niaid-leaders-outline-research-agenda-for-universal-voluntary-hiv-testing-and-treatment/

NIH Multicenter AIDS Cohort Study Commemorates 25 Years of Discovery

Date: May 6, 2009
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/831/nih-multicenter-aids-cohort-study-commemorates-25-years-of-discovery/

RESEARCH FINDINGS OPEN NEW FRONT IN FIGHT AGAINST AIDS VIRUS

Date: April 29, 2008
Source: National Institutes of Health (NIH)
Author: National Human Genome Research Institute (NHGRI)
http://aidsinfo.nih.gov/news/813/research-findings-open-new-front-in-fight-against-aids-virus/

FDA Approves the First Integrase Inhibitor, Raltegravir - October 12, 2007

Date: October 12, 2007
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/803/fda-approves-the-first-integrase-inhibitor-raltegravir---october-12-2007/

HIV Protease Inhibitors Show Potential as Cancer Treatments

Date: September 1, 2007
Source: National Institutes of Health (NIH)
Author: National Cancer Institute (NCI)
http://aidsinfo.nih.gov/news/801/hiv-protease-inhibitors-show-potential-as-cancer-treatments/

WOMEN'S RESPONSE TO ANTI-HIV THERAPY IMPROVED IF TREATMENT BEGINS SIX MONTHS AFTER EARLIER PREVENTIVE REGIMEN

Date: January 10, 2007
Source: National Institutes of Health (NIH)
Author: Office of the Director (OD) of NIH
http://aidsinfo.nih.gov/news/781/womens-response-to-anti-hiv-therapy-improved-if-treatment-begins-six-months-after-earlier-preventive-regimen/

Atazanavir Labeling Changes

Date: November 27, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/750/atazanavir-labeling-changes/

FDA Approves the First Once-a-Day Three-Drug Combination Tablet for Treatment of HIV-1

Date: July 12, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/769/fda-approves-the-first-once-a-day-three-drug-combination-tablet-for-treatment-of-hiv-1/

FDA Grants Tentative Approval of a Three-Component AIDS Drug

Date: June 30, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/768/fda-grants-tentative-approval-of-a-three-component-aids-drug/

FDA Approval of Prezista

Date: June 26, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/763/fda-approval-of-prezista/

New Guidance on Antiviral Product Development

Date: June 9, 2006
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/760/new-guidance-on-antiviral-product-development/

Statement of Elias A. Zerhouni, M.D., Jack Whitescarver, Ph.D., and Anthony S. Fauci, M.D., National Institutes of Health on The 25th Anniversary of the First Published Reports of AIDS

Date: June 2, 2006
Source: National Institutes of Health (NIH)
Author: Office of the Director (OD) of NIH
http://aidsinfo.nih.gov/news/759/statement-of-elias-a-zerhouni-md-jack-whitescarver-phd-and-anthony-s-fauci-md-national-institutes-of-health-on-the-25th-anniversary-of-the-first-published-reports-of-aids/

FDA Approval of Aptivus (tipranavir)

Date: June 21, 2005
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/731/fda-approval-of-aptivus-(tipranavir)/

New information about coadministration of REYATAZ (atazanavir) and Norvir (ritonavir) with Prilosec (omeprazole) - December 20, 2004

Date: December 20, 2004
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/722/new-information-about-coadministration-of-reyataz-(atazanavir)-and-norvir-(ritonavir)-with-prilosec-(omeprazole)---december-20-2004/

Scientists Discover New Approaches to Manipulating AIDS Virus

Date: August 16, 2004
Source: National Institutes of Health (NIH)
Author: Office of the Director (OD) of NIH
http://aidsinfo.nih.gov/news/711/scientists-discover-new-approaches-to-manipulating-aids-virus/

Thai Study Shows That Inexpensive Treatment Reduces Risk of Mother to Child HIV Transmission

Date: July 16, 2004
Source: National Institutes of Health (NIH)
Author: National Institute of Child Health and Human Development (NICHD)
http://aidsinfo.nih.gov/news/707/thai-study-shows-that-inexpensive-treatment-reduces-risk-of-mother-to-child-hiv-transmission/

Weekly Cycles of Once-Daily Anti-Drugs Could Reduce Cost of HIV Treatment

Date: May 24, 2004
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/704/weekly-cycles-of-once-daily-anti-drugs-could-reduce-cost-of-hiv-treatment/

HHS Proposes Rapid Process For Review of Fixed Dose Combination and Co-Packaged Products

Date: May 16, 2004
Source: Department of Health and Human Services (DHHS)
http://aidsinfo.nih.gov/news/705/hhs-proposes-rapid-process-for-review-of-fixed-dose-combination-and-co-packaged-products/

Guidance for Industry: Fixed Dose Combination and Co-Packaged Drug Products for Treatment of HIV

Date: May 1, 2004
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/703/guidance-for-industry-fixed-dose-combination-and-co-packaged-drug-products-for-treatment-of-hiv/

Joint Statement Issued Regarding Principles For Fixed-Dose Combination Drug Products

Date: April 8, 2004
Source: Department of Health and Human Services (DHHS)
http://aidsinfo.nih.gov/news/701/joint-statement-issued-regarding-principles-for-fixed-dose-combination-drug-products/

Transmitted Drug Resistance

Date: March 4, 2004
http://aidsetc.org/aidsetc?page=croi-11-03

Scientists Find HIV-Blocking Protein in Monkeys

Date: February 25, 2004
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/697/scientists-find-hiv-blocking-protein-in-monkeys/

Combination, Order of Anti-HIV Drugs Make a Difference in First-time Recipients

Date: December 10, 2003
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/685/combination-order-of-anti-hiv-drugs-make-a-difference-in-first-time-recipients/

Drug Warning: Once-daily Triple NRTI Regimen containing Didanosine, Lamivudine, and Tenofovir

Date: October 14, 2003
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/681/drug-warning-once-daily-triple-nrti-regimen-containing-didanosine-lamivudine-and-tenofovir/

Treatment Interruption Shows No Benefit in Drug-Resistant HIV Infection

Date: August 27, 2003
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/675/treatment-interruption-shows-no-benefit-in-drug-resistant-hiv-infection/

Important New Pharmacokinetic Data for REYATAZ(tm) (atazanavir sulfate) in combination with Viread® (tenofovir disoproxil fumarate)

Date: August 8, 2003
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/674/important-new-pharmacokinetic-data-for-reyataz(tm)-(atazanavir-sulfate)-in-combination-with-viread®-(tenofovir-disoproxil-fumarate)/

Incorporating HIV Prevention into the Medical Care of Persons Living with HIV

Date: July 18, 2003
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/671/incorporating-hiv-prevention-into-the-medical-care-of-persons-living-with-hiv/

Revised Guidelines Will Ease Selection of HIV/AIDS Treatments

Date: July 14, 2003
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/677/revised-guidelines-will-ease-selection-of-hiv-aids-treatments/

Researchers Identify Shift Towards More Treatable AIDS-Related Lymphomas

Date: June 11, 2003
Source: National Institutes of Health (NIH)
Author: National Cancer Institute (NCI)
http://aidsinfo.nih.gov/news/668/researchers-identify-shift-towards-more-treatable-aids-related-lymphomas/

Integrating Nutrition Therapy into Medical Management of HIV

Date: April 1, 2003
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/665/integrating-nutrition-therapy-into-medical-management-of-hiv/

FDA Approves First Drug in New Class of HIV Treatments

Date: March 13, 2003
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/655/fda-approves-first-drug-in-new-class-of-hiv-treatments/

7-Day-On, 7-Day-Off Regimen Could Reduce Cost, Toxicities of HIV Therapy

Date: December 3, 2001
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/582/7-day-on-7-day-off-regimen-could-reduce-cost-toxicities-of-hiv-therapy/

Comprehensive International Program of Research on AIDS

Date: December 1, 2001
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/587/comprehensive-international-program-of-research-on-aids/

New Finding May Help Doctors Prevent HIV Drug Resistance

Date: November 22, 2001
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/580/new-finding-may-help-doctors-prevent-hiv-drug-resistance/

High HIV Levels Shut Down Anti-HIV Immune Responses

Date: November 19, 2001
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/578/high-hiv-levels-shut-down-anti-hiv-immune-responses/

FDA Approves Viread for HIV-1 Infection

Date: October 29, 2001
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/576/fda-approves-viread-for-hiv-1-infection/

NIMH Scientists Discover New Details of HIV Infectious Process

Date: August 23, 2001
Source: National Institutes of Health (NIH)
Author: National Institute of Mental Health (NIMH)
http://aidsinfo.nih.gov/news/570/nimh-scientists-discover-new-details-of-hiv-infectious-process/

HIV Infection in Women

Date: May 1, 2001
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/82/hiv-infection-in-women/

Mother-to-Infant HIV Transmission Rate Less Than 2% in Phase III Perinatal Trial

Date: February 8, 2001
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/557/mother-to-infant-hiv-transmission-rate-less-than-2--in-phase-iii-perinatal-trial/

FAUCI PRESENTS NEW DATA ON STRUCTURED INTERMITTENT THERAPY AT XIIITH WORLD AIDS CONFERENCE IN DURBAN, SOUTH AFRICA

Date: July 11, 2000
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/532/fauci-presents-new-data-on-structured-intermittent-therapy-at-xiiith-world-aids-conference-in-durban-south-africa/

HIV Vaccine Glossary

Date: May 1, 2000
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/128/hiv-vaccine-glossary/

NIAID Researchers Discover Why Some HIV-Infected People Don't Develop AIDS

Date: March 15, 2000
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/520/niaid-researchers-discover-why-some-hiv-infected-people-dont-develop-aids/

NIH Clinical Center Study Demonstrates Dangerous Interaction Between St. John's Wort and an HIV Protease Inhibitor

Date: February 10, 2000
Source: National Institutes of Health (NIH)
http://aidsinfo.nih.gov/news/519/nih-clinical-center-study-demonstrates-dangerous-interaction-between-st-johns-wort-and-an-hiv-protease-inhibitor/

Newly Updated HIV Treatment Guidelines for Adults and Adolescents Available on the World Wide Web

Date: January 28, 2000
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/517/newly-updated-hiv-treatment-guidelines-for-adults-and-adolescents-available-on-the-world-wide-web/

NIAID Renews Funding for the Adult AIDS Clinical Trials Group

Date: November 2, 1999
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/515/niaid-renews-funding-for-the-adult-aids-clinical-trials-group/

NIAID: Planning for the 21st Century

Date: November 1, 1999
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/518/niaid-planning-for-the-21st-century/

NIAID Renews Funding for Multicenter AIDS Cohort Study

Date: April 20, 1999
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/480/niaid-renews-funding-for-multicenter-aids-cohort-study/

Scientists Report New Lead in the Genetics of HIV Resistance

Date: March 11, 1999
Source: National Institutes of Health (NIH)
Author: National Cancer Institute (NCI)
http://aidsinfo.nih.gov/news/481/scientists-report-new-lead-in-the-genetics-of-hiv-resistance/

Questions and Answers on the Thailand Phase III Vaccine Study and CDC's Collaboration

Date: February 3, 1999
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/486/questions-and-answers-on-the-thailand-phase-iii-vaccine-study-and-cdcs-collaboration/

Study Finds Less Intensive Treatments may not Maintain HIV Suppression

Date: October 28, 1998
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/449/study-finds-less-intensive-treatments-may-not-maintain-hiv-suppression/

Scientist Report New Strategy to Rapidly Assess Effectiveness of AIDS Drugs in Children

Date: September 22, 1998
Source: National Institutes of Health (NIH)
Author: National Cancer Institute (NCI)
http://aidsinfo.nih.gov/news/445/scientist-report-new-strategy-to-rapidly-assess-effectiveness-of-aids-drugs-in-children/

New Laboratory Findings May Help Explain Immunity to HIV in Thai Female Prostitutes

Date: July 2, 1998
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/434/new-laboratory-findings-may-help-explain-immunity-to-hiv-in-thai-female-prostitutes/

Difficulties with HIV Treatment Adherence Raise Concerns About Drug Resistance

Date: July 1, 1998
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/435/difficulties-with-hiv-treatment-adherence-raise-concerns-about-drug-resistance/

Fauci to Present New Insights into HIV Latency at 12th World AIDS Conference

Date: June 30, 1998
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/423/fauci-to-present-new-insights-into-hiv-latency-at-12th-world-aids-conference/

Combating Complacency in HIV Prevention

Date: June 27, 1998
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/437/combating-complacency-in-hiv-prevention/

Interleukin-12 Helps Control Mycobacterium Avium Infection

Date: June 1, 1998
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/417/interleukin-12-helps-control-mycobacterium-avium-infection/

Trojan Horse Virus Controls HIV Infection

Date: September 4, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/385/trojan-horse-virus-controls-hiv-infection/

Two Drugs Better Than One for Treating Children with Symptomatic HIV

Date: June 26, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/376/two-drugs-better-than-one-for-treating-children-with-symptomatic-hiv/

Draft HIV/AIDS Treatment Guidelines Available

Date: June 19, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/375/draft-hiv-aids-treatment-guidelines-available/

CDC Statement On Post-exposure Prophylaxis For Exposures To HIV

Date: June 10, 1997
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/367/cdc-statement-on-post-exposure-prophylaxis-for-exposures-to-hiv/

CDC Studies of AZT to Prevent Mother-to-Child HIV Transmission in Developing Countries

Date: June 1, 1997
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/363/cdc-studies-of-azt-to-prevent-mother-to-child-hiv-transmission-in-developing-countries/

1996 TB Declines Indicate U.S. is Back on Track But Not Without Serious Challenges

Date: March 24, 1997
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/338/1996-tb-declines-indicate-us-is-back-on-track-but-not-without-serious-challenges/

Study Confirms that Combination Treatment Using a Protease Inhibitor Can Delay HIV Disease Progression and Death

Date: February 24, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/333/study-confirms-that-combination-treatment-using-a-protease-inhibitor-can-delay-hiv-disease-progression-and-death/

CCR5 and Protection Against HIV-1 Infection

Date: February 1, 1997
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/457/ccr5-and-protection-against-hiv-1-infection/

Fauci Lab Presents New Data on AIDS Pathogenesis, Treatment at Retroviruses Conference

Date: January 22, 1997
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/329/fauci-lab-presents-new-data-on-aids-pathogenesis-treatment-at-retroviruses-conference/

Important Information on the Combination of Zidovudine (ZDV) and Stavudine (d4T) in ZDV-experienced HIV-Infected Patients

Date: November 22, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/28/important-information-on-the-combination-of-zidovudine-(zdv)-and-stavudine-(d4t)-in-zdv-experienced-hiv-infected-patients/

IL-2 Therapy Doubles CD4+ T Cell Counts in HIV-Infected People

Date: October 30, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/314/il-2-therapy-doubles-cd4--t-cell-counts-in-hiv-infected-people/

Notice to Readers: Clinical Update: Impact of HIV Protease Inhibitors on the Treatment of HIV-Infected Tuberculosis Patients with Rifampin

Date: October 25, 1996
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/316/notice-to-readers-clinical-update-impact-of-hiv-protease-inhibitors-on-the-treatment-of-hiv-infected-tuberculosis-patients-with-rifampin/

Scientists Confirm Natural Resistance to HIV-1

Date: September 26, 1996
Source: National Institutes of Health (NIH)
Author: National Cancer Institute (NCI)
http://aidsinfo.nih.gov/news/310/scientists-confirm-natural-resistance-to-hiv-1/

CRCRA Researchers Present OI Studies at Vancouver

Date: September 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/319/crcra-researchers-present-oi-studies-at-vancouver/

Nevirapine Approved by FDA: First non-nucleoside reverse transcriptase inhibitor

Date: September 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/322/nevirapine-approved-by-fda-first-non-nucleoside-reverse-transcriptase-inhibitor/

Fluconazole Prevents Yeast Infections in Women with HIV

Date: July 10, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/285/fluconazole-prevents-yeast-infections-in-women-with-hiv/

NIAID Study Finds Initial Intermittent Treatment Effective for HIV-Related TB

Date: July 9, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/283/niaid-study-finds-initial-intermittent-treatment-effective-for-hiv-related-tb/

The Protease Inhibitors

Date: July 1, 1996
Source: Food and Drug Administration (FDA)
http://aidsinfo.nih.gov/news/298/the-protease-inhibitors/

Studies Shed New Light on Mother-to-Infant HIV Transmission

Date: June 19, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/265/studies-shed-new-light-on-mother-to-infant-hiv-transmission/

Notice to Readers Update: Provisional Public Health Service Recommendations For Chemoprophylaxis After Occupational Exposure to HIV

Date: June 7, 1996
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/263/notice-to-readers-update-provisional-public-health-service-recommendations-for-chemoprophylaxis-after-occupational-exposure-to-hiv/

Antiretrovirals Plus Immunomodulators: Didanosine/Interferon-alpha Combination Shows Promise

Date: June 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/293/antiretrovirals-plus-immunomodulators-didanosine-interferon-alpha-combination-shows-promise/

Highlights of AIDS Vaccine Meeting

Date: March 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/281/highlights-of-aids-vaccine-meeting/

Journal Watch

Date: March 1, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/280/journal-watch/

ACTG PROTOCOL 152: Questions and Answers

Date: February 28, 1996
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/235/actg-protocol-152-questions-and-answers/

ACTG 175: Anti-HIV Therapy Lowers Risk of AIDS, Death in Patients with Intermediate-Stage HIV Disease.

Date: September 14, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/197/actg-175-anti-hiv-therapy-lowers-risk-of-aids-death-in-patients-with-intermediate-stage-hiv-disease/

Questions and Answers: AIDS Clinical Trials Group (ACTG) 175

Date: September 14, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/196/questions-and-answers-aids-clinical-trials-group-(actg)-175/

The Relationship between the Human Immunodeficiency Virus and the Acquired Immunodeficiency Syndrome (Part I)

Date: July 24, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/218/the-relationship-between-the-human-immunodeficiency-virus-and-the-acquired-immunodeficiency-syndrome-(part-i)/

USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus

Date: July 14, 1995
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/193/usphs-idsa-guidelines-for-the-prevention-of-opportunistic-infections-in-persons-infected-with-human-immunodeficiency-virus/

Public Health Service Recommendations for Human Immunodeficiency Virus Counseling and Voluntary Testing for Pregnant Women

Date: July 7, 1995
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/192/public-health-service-recommendations-for-human-immunodeficiency-virus-counseling-and-voluntary-testing-for-pregnant-women/

The World as a Hot Zone: New and Re-Emerging Diseases

Date: February 21, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/170/the-world-as-a-hot-zone-new-and-re-emerging-diseases/

Chimpanzee Vaccine Model Protects Against HIV-1 Infection

Date: February 1, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/166/chimpanzee-vaccine-model-protects-against-hiv-1-infection/

Gene Therapy for HIV Infection

Date: February 1, 1995
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/169/gene-therapy-for-hiv-infection/

NIAID Mobilizes Teams of Scientists to Advance Novel AIDS Therapies

Date: September 1, 1994
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/135/niaid-mobilizes-teams-of-scientists-to-advance-novel-aids-therapies/

Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus

Date: August 5, 1994
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/144/recommendations-of-the-us-public-health-service-task-force-on-the-use-of-zidovudine-to-reduce-perinatal-transmission-of-human-immunodeficiency-virus/

AIDS AND OPPORTUNISTIC INFECTIONS

Date: April 1, 1994
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/71/aids-and-opportunistic-infections/

Acyclovir-Resistant Genital Herpes Found in Person with Healthy Immune System

Date: December 8, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/92/acyclovir-resistant-genital-herpes-found-in-person-with-healthy-immune-system/

HIV Therapy Recommendations Issued

Date: December 1, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/91/hiv-therapy-recommendations-issued/

Fauci: AIDS Therapies Must Address Complexity of HIV Disease Process

Date: October 18, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/79/fauci-aids-therapies-must-address-complexity-of-hiv-disease-process/

Two Studies Examine Drugs to Prevent HIV-Associated Opportunistic Infections

Date: July 26, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/67/two-studies-examine-drugs-to-prevent-hiv-associated-opportunistic-infections/

HIV Therapy Guidelines Issued

Date: June 25, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/65/hiv-therapy-guidelines-issued/

Trial of TAT Antagonist as Therapy for HIV Infection Altered

Date: June 10, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/57/trial-of-tat-antagonist-as-therapy-for-hiv-infection-altered/

ACTG 116B/117: High Levels of AZT Resistance May Predict HIV Disease Progression

Date: June 8, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/54/actg-116b-117-high-levels-of-azt-resistance-may-predict-hiv-disease-progression/

Variations in Response to HIV Exposure and Infection: Long- Term Survivors and Others

Date: June 1, 1993
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/106/variations-in-response-to-hiv-exposure-and-infection-long--term-survivors-and-others/

1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults

Date: December 8, 1992
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/9/1993-revised-classification-system-for-hiv-infection-and-expanded-surveillance-case-definition-for-aids-among-adolescents-and-adults/

Date: May 1, 1991
Source: National Institutes of Health (NIH)
Author: National Institute of Allergy and Infectious Diseases (NIAID)
http://aidsinfo.nih.gov/news/78/niaid-aids-research-opportunistic-infections-aids-related-herpes-simplex-virus-infection/

Public Health Service Statement on Management of Occupational Exposure to Human Immunodeficiency Virus, Including Considerations Regarding Zidovudine Postexposure Use

Date: January 26, 1990
Source: Centers for Disease Control and Prevention (CDC)
http://aidsinfo.nih.gov/news/113/public-health-service-statement-on-management-of-occupational-exposure-to-human-immunodeficiency-virus-including-considerations-regarding-zidovudine-postexposure-use/